Fig. 2

Patient-reported preference for quarterly or monthly fremanezumab dosing regimen^a. CM, chronic migraine; EM, episodic migraine. ^aPatients responded to the following question: “If the effectiveness was similar no matter which option you choose, would you rather take the injectable migraine medicine once a month, or once every 3 months?” This question had the following response options: “monthly” or “once every 3 months”